Status:
UNKNOWN
Efficacy of an Internet-based Psychological Intervention for Problem Gambling and Gambling Disorder
Lead Sponsor:
Universitat Jaume I
Conditions:
Pathological Gambling
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to assess the efficacy of an online CBT-based intervention combined with an Ecological Momentary Intervention (EMI) and different complementary tools for the treatment of prob...
Detailed Description
Gambling Disorder is a prevalent non-substance use disorder, which contrasts with the low number of people requesting treatment. Information and Communication Technologies (ICT) could help to enhance ...
Eligibility Criteria
Inclusion
- Be 18 years or older.
- Willingness to participate in the study and sign informed consent.
- To have and handle the computer, Internet and an email address.
- Ability to understand, read and write Spanish.
- Based on the cut-off points established by the Norc diagnostic screen for gambling disorders (NODS; adapted by Becoña, 2004): be a problem gambler (3-4 items) or a pathological gambler (5 or more items).
- Willingness to provide the name of a co-therapist to validate the information provided, as well as to be able to locate the patient in follow-ups.
- Willing to provide follow-up data on gambling.
Exclusion
- Any serious mental disorder (Bipolar and Related Disorders and Schizophrenia Spectrum and Other Psychotic Disorders), medical illness, and moderate or severe alcohol and/or substance use disorder, that prevents the program from being carried out.
- If their gambling behaviour occurs in the context of a Maniac Episode or because of the intake of dopaminergic medication (e.g. Parkinson's disease).
- The presence of high suicidal risk.
- Receiving another psychological treatment while the study is still ongoing.
- Receiving pharmacological treatment is not an exclusion criterion during the study period, but participants having an increase and/or change in the medication 2 months prior to enrollment will not be considered for the trial. Also, the increase and/or change in the medication during the study period in the experimental group will imply the participant's exclusion from subsequent analyses (a decrease in pharmacological treatment is accepted).
Key Trial Info
Start Date :
February 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT04074681
Start Date
February 1 2023
End Date
December 1 2024
Last Update
May 24 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.